Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soft vs Conventional Ovarian Stimulation for Poor Responders
NCT04193930Withdrawn
- Sponsor
- Assiut University
- Start
- Jan 2021
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in poor ovarian response (POR) (2 arms), sponsored by Assiut University. Primary endpoint: Total gonadotrophins dose at 14 days. Planned start Jan 2021; status: withdrawn.
02
Drugs
letrozole
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT04193930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193930.